Malcolm Lloyd-Smith Insider Profile
4 Followers
Malcolm Lloyd-Smith, Chief Integration Officer at Neurocrine, holds 42.34K shares in Neurocrine (Ticker: NBIX), holds 0.00 shares in Cadence Pharma (Ticker: CADX).
Malcolm Lloyd-Smith's Trading History
| NBIXNeurocrine | Feb 08, 2023 | Chief Integration Officer | Uninformative Sell | 1.57M | $7.09M | |
| CADXCadence Pharma | Mar 21, 2014 | ― | Uninformative Sell | 32.65K | ― |
You May Also Like
Malcolm Lloyd-Smith insider profile FAQ
What stocks does Malcolm Lloyd-Smith hold?
Malcolm Lloyd-Smith holds: NBIX, CADX stocks.
What was Malcolm Lloyd-Smith’s latest transaction?
Malcolm Lloyd-Smith’s latest transaction was an Uninformative Sell of $1.57M.
What is Malcolm Lloyd-Smith's role in Neurocrine?
Malcolm Lloyd-Smith's role in Neurocrine is Chief Integration Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
